A retrospective study of predictive factors of skin toxicities in NHL patients treated with bendamustine alone or in BR therapy
Latest Information Update: 27 Jul 2021
At a glance
- Drugs Bendamustine (Primary) ; Rituximab (Primary) ; Carboplatin; Cisplatin; Cladribine; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Fludarabine; Ifosfamide; Irinotecan; Methotrexate; Methylprednisolone; Mitoxantrone; Pirarubicin; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 27 Jul 2021 New trial record